Recent Security Class Actions

Fennec Pharmaceuticals Inc. Common Stock (NASDAQ: FENC)

Company Name:Fennec Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: FENC
Class Period Start:05/28/2021
Class Period End (inclusive):11/26/2021
Filing Deadline:04/11/2022

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Fennec had not successfully remediated, and overstated its efforts to remediate, issues with the manufacturing facility of its drug product manufacturer for PEDMARK; (ii) as a result, the FDA was unlikely to approve the Resubmitted Pedmark NDA; (iii) accordingly, the regulatory and commercial prospects of the Resubmitted Pedmark NDA were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.